Skip to content
    Real-World Studies

    Development of a patient-reported outcomes registry for patients with brain tumours (BEACON)

    Sanderson et alESMO Real-World Data and Digital Oncology

    Capturing patient-reported outcomes (PROs) provides critical data for patient-centered neuro-oncology care and clinical research. The BEACON registry was developed as a prospective, noninterventional digital platform designed to capture the lived experiences of adult patients following a brain tumour diagnosis. Codesigned directly with brain cancer patients in collaboration with BioGrid Australia Limited, the registry architecture incorporates four core components: self-registration with dynamic consent management, administration of validated PRO instruments, capture of frequently overlooked domains such as financial toxicity and informal support systems, and real-time data analytics.
    During its formative preimplementation phase, BEACON was evaluated by a cohort of 10 volunteer participants comprising brain cancer patients, caregivers, and public representatives to assess language accessibility, platform navigation, and satisfaction. The testing confirmed cross-device compatibility and demonstrated positive user satisfaction. User insights informed practical optimizations, including the consolidation of consent documentation, refined password creation parameters, and color-coded response tracking to clearly separate historical from active entries.
    BEACON operates as a self-referral, population-accessible digital platform linked directly with clinical datasets from the Brain tumour Registry Australia INnovation and translation clinical registry, establishing a scalable infrastructure to support translational investigations and future registry-based clinical trials.

    Key Takeaways

    • Formative preimplementation testing among 10 brain tumour patients, carers, and members of the public confirmed cross-device compatibility, high perceived value, and overall system usability.
    • User feedback prompted specific interface refinements prior to wide deployment, including consolidated consent forms, improved password definitions, and adjusted visual color contrasts to distinguish historic from current survey responses.
    Read the original sourceESMO Real-World Data and Digital Oncology